Becker’s: For Abridge, ‘Note-Taking Was Just the Start’

📥 Becker’s Healthcare: With a $5.3B valuation, Abridge sends a message: Note-taking was just the start

It starts with the conversation, and it was always about more than clinical notes. 

Abridge is an AI platform company, serving all health system stakeholders. A new paradigm of care delivers intelligence upstream so clinicians, nurses, and revenue cycle teams can operate with unparalleled efficiency. 

“Despite nearly doubling its valuation since February, the company still seems to operate with the urgency and edge of a younger startup, eager to prove its tenacity.”

Read much more about the latest developments at Abridge.